نمایش پرونده ساده آیتم

dc.contributor.authorBarzegar-Jalali, S
dc.contributor.authorHatami-Sadabadi, F
dc.date.accessioned2018-08-26T08:32:29Z
dc.date.available2018-08-26T08:32:29Z
dc.date.issued2004
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52297
dc.description.abstractAim: The status of a new sign for diagnosing rheumatoid arthritis is discussed for the first time in this study. It is defined as marked tenderness on the anterior surface of leg (shin) on pressure of about 4 kg by thumb. The sign has been denoted as 'Avicenna sign'. Methods: All cases were selected by convenient sampling from patients who were referred to two rheumatology clinics in Tabriz, Iran. Sample size was calculated as 618 using Cochran's sampling equation. Diagnosis of rheumatoid arthritis was made according to American Rheumatism Association criteria. Two physicians were asked to examine the sign on all of the selected patients separately. One of them (a general physician) was not informed about methodology and objectives of the study whereas a rheumatologist was well informed and he collected data using a written questionnaire. Test-retest method and discriminant analysis were used to test reliability and validity of the sign for diagnosing rheumatoid arthritis. The effects of intervening variables including osteoporosis and consumption of some medications were controlled employing Chi-square test. Results: When the general physician examined patients with Avicenna sign to diagnose rheumatoid arthritis, sensitivity and specificity of the sign were reported as 77.1% and 98.4%, respectively. The corresponding values were 81.3% and 98.4%, respectively, when the rheumatologist examined the patients. Conclusions: This study suggested considerable diagnostic value of the sign for rheumatoid arthritis. Consumption of acetaminophen or NSAIDs had no effect on the status of Avicenna sign while taking gluccocorticoids made it unreliable for diagnostic purposes. é Asia Pacific League of Associations for Rheumatology.
dc.language.isoEnglish
dc.relation.ispartofAPLAR Journal of Rheumatology
dc.subjectglucocorticoid
dc.subjectnonsteroid antiinflammatory agent
dc.subjectparacetamol
dc.subjectadult
dc.subjectarticle
dc.subjectavicenna sign
dc.subjectbone pain
dc.subjectcalculation
dc.subjectchi square test
dc.subjectdiagnostic value
dc.subjectdiscriminant analysis
dc.subjectdisease marker
dc.subjectfemale
dc.subjecthuman
dc.subjectIran
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectmethodology
dc.subjectosteoporosis
dc.subjectphysical examination
dc.subjectphysician
dc.subjectpressure
dc.subjectpriority journal
dc.subjectquestionnaire
dc.subjectreliability
dc.subjectrheumatoid arthritis
dc.subjectrheumatology
dc.subjectsymptom
dc.subjecttibia
dc.titleA new diagnostic sign for rheumatoid arthritis: Avicenna sign
dc.typeArticle
dc.citation.volume7
dc.citation.issue2
dc.citation.spage117
dc.citation.epage122
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.1111/j.1479-8077.2004.00087.x


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم